References
- Akashi A., Chiba T., Suzuki I., Hashimoto H. Pharmacology of budralazine, a new antihypertensive drug. Arch. int. Pharmacodyn. 1978; 135: 134–146
- Chiba T., Hirohashi M., Suzuki I., Tanaka S., Watanabe K., Akashi A. Characterization of the Vasodilator Action of Antihypertensive Drug Budralazine. Arzneim.-Forsch. 1983; 33: 112–116
- Stein D. H., Hecht H. H. Cardiovascular and renal responses to the combination of hexamethonium and 1-hydrazinophthalazine (Apresoline) in hypertensive subjects. J. Clin. Invest. 1955; 34: 867–874
- Åblad B. A study of the mechanism of hemodynamic effects of hydralazine in man. Acta Pharmacol. Toxicol. 1963; 20(suppl.1)1–15
- Yoshioka M., Togashi H., Minami M., Saito H. Effects of hydralazine on adrenal and cardiac sympathetic nerve activity in anesthetized rats. Res. Commun. Chem. Pathol. Pharmacol. 1986; 54: 313–320
- Akashi A., Chiba T., Kasahara A. Antihypertensive activity of 1-[2- (1,3)-dimethyl-2-butenylidene]-phthalazine (DJ-1461), a new phthalazine derivatives. European J. Pharmacol. 1974; 29: 161–164
- Konno K., Nonaka K., Ueno A. Hypotensive and cardiovascular action of budralazine in unanesthetized and unrestrained dogs. Arzneim.-Forsch. 1981; 31: 1072–1075
- Takeuchi J., Taniguchi K., Iesaka Y. Long effects of budralazine (DJ-1461) on essential Hypertension. Shinryo to Shinyaku 1980; 17: 2381–2385, (in Japanese)
- Yoshinaga K., Miura Y. Treatment of hypertension with budralazine. Progress in Medicine 1985; 5: 2223–2232, (in Japanese)
- Sapru H. N., Krieger A. J. Carotid and aortic chemorceptor function in the rat. J. Appl. Physiol. 1977; 42: 344–348